JOSIE WEBER: Open Payments
NPI 1073240115 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 41 payments from 15 companies in 2025. Trend: 2023 $419 · 2024 $697 · 2025 $658
Food & beverage: $587Education: $71
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 17 | $193 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| ABBVIE INC. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Indivior Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
Products named: FANAPT, REXULTI, CAPLYTA, COBENFY, AUSTEDO XR, VRAYLAR, INGREZZA, SUBLOCADE.
Industry payments across IN — which companies pay providers there.
